Early selection in a randomized phase II clinical trial

Statistics in Medicine

Volumn 21, Issue 12, 2002, Pages 1711-1726

  Steinberg, Seth M ^a   Venzon, David J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Randomized phase II trial; Selection theory; Two stage phase II trial

Indexed keywords

ARTICLE; CANCER THERAPY; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HYPOTHESIS; MEDICAL DECISION MAKING; METHODOLOGY; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; STATISTICAL PARAMETERS;

CLINICAL TRIALS, PHASE II; HUMANS; INTERLEUKIN-2; MELANOMA; RANDOMIZED CONTROLLED TRIALS; SAMPLE SIZE; VACCINES, DNA;

EID: 0037198992     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.1150     Document Type: Article

References (17)

1. Optimal two-stage designs for phase II clinical trials
2. Clinical Trials in Cancer
3. Planning the size and duration of a clinical trial studying the time to some critical event
4. Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observation
5. Nomograms for calculating the number of patients needed for a clinical trial with survival as an endpoint
6. Power and sample size calculations: A review and computer program
7. Sample size and power determination for stratified clinical trials
8. Designing clinical trials with arbitrary specification of survival functions and for the log rank or generalized Wilcoxon test
9. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
10. Randomized phase II clinical trials
11. Two-stage selection and testing designs for comparative clinical trials
12. A two-stage design for choosing among several experimental treatments and a control in clinical trials
13. Confidence limits for probability of response in multistage phase II clinical trials
14. Confidence intervals for a binomial parameter based on multistage tests